MONTREAL--(BUSINESS WIRE)--The organizers are pleased to announce the 1st Edition of Sweet Pharma Day on April 23rd, 2019, the day before the Effervescence Conference. This invitation-only event in the Greater Montreal invites start-up and small biotech companies across Canada to apply and the ones selected will present in front of at least six (6) large pharma companies for a potential collaboration and/or partnership. It will gather all key players in the Canadian life sciences ecosystem, including venture capitalists, government and association representatives.
Are you a start-up or small biotech company with less than 25 employees conducting innovative research and development with strong commercial potential? If yes, you may be one of the participants chosen to present in front of the invited large pharma companies.
To apply to this event, CEOs must provide a 2-page executive summary and a short slide deck (max 5 slides) to describe their disruptive technology, target indications and differentiation features. Documents must be submitted no later than Friday March 1st, 2019, 5PM at the following email address: firstname.lastname@example.org. The invited large pharma companies will select participants and CEOs will be contacted no later than March 15th, 2019.
The “Sweet 16” small biotech companies will present at the Sugar Shack, Sucrerie de la Montagne de Rigaud, on April 23rd, 2019, in front of invited large pharma companies, to be announced shortly. This invitation-only event is the sweet spot for participating companies with a promising future to network. Moreover, the best presentation will receive $2,500 at the end of the day.
The Sweet Pharma Day is generously supported by Gold Sponsors: the Fonds de Solidarité des Travailleurs du Québec (FSTQ), Merck & Co, Robic; by Silver Sponsor: Royal Bank of Canada (RBC); and Bronze Sponsors: Novateur Ventures and Avir Pharma.
About Sweet Pharma Day
The Sweet Pharma Day is an invitation-only event in life sciences in Canada, taking place in the Greater Montreal area. Its first edition is organized and supported by AmorChem, BIOTECanada, BIOQuébec, Life Sciences British Columbia, Montreal InVivo and Montreal International. It provides small biotech CEOs to closely interact with the global division of large pharma companies and key venture capital funds with a unique opportunity to build future collaborations and partnerships, and the sweet pleasure of maple syrup.